What is the recommended treatment for a 35-year-old patient with supraventricular tachycardia presenting at a heart rate of 170 beats per minute?

Treatment for 35-Year-Old with SVT at 170 bpm

Begin immediately with vagal maneuvers (modified Valsalva maneuver in supine position for 10-30 seconds), and if unsuccessful, administer intravenous adenosine 6 mg rapid IV push followed by 20 mL saline flush—this will terminate the arrhythmia in approximately 95% of cases. 1

Algorithmic Approach to Acute Management

Step 1: Assess Hemodynamic Stability

First, determine if your patient is hemodynamically unstable (hypotension, altered mental status, chest pain, acute heart failure, or shock):

• If UNSTABLE: Proceed directly to synchronized cardioversion 1
• If STABLE: Continue with stepwise approach below

Step 2: First-Line Therapy (Hemodynamically Stable)

Vagal Maneuvers - Attempt immediately 1:

• Modified Valsalva maneuver: Patient bears down against closed glottis for 10-30 seconds (equivalent to 30-40 mmHg intrathoracic pressure) in supine position
• If unsuccessful, try carotid sinus massage (after confirming no bruit): Apply steady pressure over right or left carotid sinus for 5-10 seconds
• Alternative: Apply ice-cold wet towel to face (diving reflex)
• Success rate: 27.7% when switching between techniques 1

Step 3: Pharmacologic Therapy

Adenosine - Drug of choice when vagal maneuvers fail 2, 1:

• Dose: 6 mg rapid IV push via proximal IV, followed immediately by 20 mL saline flush
• If unsuccessful after 1-2 minutes: Give 12 mg rapid IV push
• Success rate: 90-95% for AVNRT/AVRT 1, 3
• Critical: Have cardioversion equipment ready—adenosine can precipitate atrial fibrillation with rapid ventricular response 1
• Record continuous ECG during administration to distinguish failure versus successful termination with immediate reinitiation 1

Step 4: Alternative Pharmacologic Options (If Adenosine Fails/Contraindicated)

For hemodynamically stable patients 1:

Intravenous calcium channel blockers or beta-blockers (reasonable alternatives):

• Diltiazem or verapamil IV: Particularly effective for AVNRT conversion (80-98% success rate) 1
• Beta-blockers IV (e.g., metoprolol, esmolol): Excellent safety profile though slightly less effective than calcium channel blockers 1

CRITICAL CAVEATS:

• DO NOT use verapamil/diltiazem if:
  • Pre-excitation (WPW) visible on ECG—risk of ventricular fibrillation 1
  • Suspected ventricular tachycardia
  • Systolic heart failure present
• Ensure you have excluded wide-complex tachycardia before administering AV nodal blockers

Step 5: Synchronized Cardioversion

Indications 1:

• Hemodynamic instability at any point
• Failure of pharmacologic therapy in stable patient
• Contraindication to medications

Highly effective: Terminates SVT in nearly 100% of cases 1

Important Clinical Considerations

What Changed in Recent Guidelines

The 2019 ESC guidelines 2 made significant updates:

• Adenosine remains drug of choice (unchanged, Class I recommendation)
• Downgraded: Verapamil/diltiazem for acute narrow-QRS tachycardias (though still reasonable)
• No longer recommended: Amiodarone and digoxin for acute narrow-QRS SVT management
• Upgraded: Beta-blockers for acute management

Common Pitfalls to Avoid

1. Pre-excitation trap: Always check for delta waves on baseline ECG. If present and patient develops atrial fibrillation during treatment, AV nodal blockers (adenosine, verapamil, diltiazem, beta-blockers) can accelerate conduction through accessory pathway → ventricular fibrillation 1

2. Adenosine administration errors: Must use rapid push via proximal IV with immediate saline flush. Slow administration = treatment failure 1

3. Assuming hemodynamic stability: At 170 bpm in a 35-year-old, patient may appear stable initially but can deteriorate. Reassess continuously and have cardioversion immediately available 1

4. Post-conversion arrhythmias: Expect atrial/ventricular premature complexes immediately after conversion (whether from adenosine or cardioversion) that may reinitiate tachycardia—may need antiarrhythmic to prevent acute reinitiation 1

Long-term Management

After acute termination, refer to electrophysiology for catheter ablation consideration 3, 4, 5:

• Catheter ablation is now first-line therapy for preventing recurrence (2019 ESC guidelines upgrade) 2, 5
• Single procedure success: 94.3-98.5% 3
• Very low complication rate with modern techniques 5
• Superior to long-term pharmacotherapy for quality of life 3, 4